A Phase 1b Open-Label, Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (GS-9973) with Chemotherapy in Adult Subjects with Acute Relapsed or Refractory Acute Lymphoid Leukemia (ALL)

Type of Cancer
Leukemia

Site
Hackensack

Sponsor
Gilead

Protocol Number
GS-US-339-1560

To Learn More Call
201-510-0910